top of page
Precision Therapy for Diabetes
Pipeline
Our precision therapies target insulin-dependent diabetes, featuring a mAb43 monotherapy and an array of combination therapies utilizing islet-directed antibody-drug conjugates (ADCs).
These multifunctional biologics comprise four interconnected modules:
1. An islet-homing module guiding systematically administered ADCs to pancreatic islets.
2. A mitogenic module stimulating adult beta cell growth.
3. A cell-surface masking module providing a protective shield against autoimmune attacks in T1D.
4. A stress-alleviating module designed to protect β-cells from inflammation-induced apoptosis in T2D.
​
​
bottom of page